The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
Matt Durot, Senior Reporter at Forbes, joins Cheddar to unpack all things Elon Musk including his soaring wealth, relationship to Trump and if he has a will.
David McKillips, President and CEO of CEC Entertainment, discusses the ongoing Chuck E. Cheese brand refresh, new locations, updated play spaces and more.
Lila MacLellan, Senior Writer at Fortune, discusses how the healthcare industry is reacting to the murder of United Healthcare CEO Brian Thompson. Watch!
Matt Hougan from Bitwise Asset Management joins Cheddar to discuss how and why Bitcoin is continuing to rise and what the future holds for the cryptocurrency.
Should real estate agents fear AI? Tushar Garg CEO at Flyhomes says no. He joined Cheddar to discuss the future of AI in the Real Estate business and more.
